Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

MHRA approves license extension for Novartis’ breast cancer targeted therapy

December 24, 2021 Medical Communications

The MHRA has approved the marketing authorisation to extend Novartis’ licence in Great Britain for Piqray (alpelisib), for use in …
News
moderna_norwood_plant

Moderna CEO says Omicron booster could begin development within weeks

December 21, 2021 Medical Communications

Stephane Bancel, CEO of Moderna, said that the company could begin work on a booster shot against the Omicron variant …
News

Vifor Pharma announces positive results from Phase IIIb trial of heart failure treatment

December 21, 2021 Medical Communications

Vifor Pharma has announced positive findings for the completed Phase IIIb DIAMOND trial of Veltassa, in heart failure patients with …
News

CDC recommends mRNA vaccines over J&J

December 17, 2021 Medical Communications

The CDC has recommended Pfizer-BioNTech and Moderna COVID-19 vaccines over Johnson & Johnson jabs. The recommendation from CDC Director Dr …
News

COVID-19 booster vaccine triggers immune response in days, not weeks, scientists say

December 17, 2021 Medical Communications

COVID-19 booster jabs trigger an immune response in a matter of days, rather than weeks, scientists have shared. Data suggests …
News

NICE recommends offering PrEP to those at high risk of HIV

December 17, 2021 Medical Communications

People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the …
News

India’s Serum Novavax jab to be launched for children in six months

December 14, 2021 Medical Communications

The Serum Institute of India (SII) plans to launch the Novavax COVID-19 vaccine for children in the country in six …
News
astrazeneca_plaque

Samsung Biologics and AstraZeneca expand partnership to include COVID-19 and cancer therapy

December 14, 2021 Medical Communications

Contract development and manufacturing organisation (CDMO), Samsung Biologics, and AstraZeneca, continue their strategic collaboration which was initiated in May 2021. …
News
chris_hewitt_head_shot

Amarin appoints Dr Chris Hewitt UK and Ireland Medical Director

December 13, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amarin has appointed Dr Chris Hewitt as UK and Ireland Medical Director. Hewitt is a UK-trained physician with many years …
Appointment

CDC authorise Pfizer boosters for 16- and 17-year-olds

December 10, 2021 Medical Communications

The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The …
News

FDA approves expansion for ZYNRELEF

December 10, 2021 Medical Communications

The FDA has approved Heron Therapeutics’ supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam), to significantly expand the …
News

UK study shows Pfizer and Moderna jabs give best COVID-19 protection

December 3, 2021 Medical Communications

The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …
News

WHO say Delta measures will help fight Omicron

December 3, 2021 Medical Communications

WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …
News

Researchers develop blood test for HPV-associated head and neck cancer

December 3, 2021 Medical Communications

A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …
News

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

December 3, 2021 Medical Communications

Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026